Neptune Bio-Innovations Holdings Pty Ltd
Committed to its business ethos in delivering the best, most premium Australian products to both the domestic and export markets, BFC invested in Neptune Bio-Innovations (NBI) in 2015; an Australian based innovative Research and Development company which provides customised solutions in the food and nutrition arena.
NBI uses technology driven solutions to formulate and develop healthy food and food ingredients. It has several own brands, but primarily provides commercially ready products to its clients in the food and beverage and pharmaceutical industries and/or proprietary ingredients for its clients products.
The company holds trademarks for Naturlyte™️, Sweetin™️, Lo-Sal 50™️, NepTrim™️ and Moo™️. Provisional IP rights are held for Sweetin™️. The intellectual property of NBI is protected through a ‘modular development system’ which makes theft of trade secrets difficult. No one particular scientist or staff member in NBI has the knowledge of the entire development process of NBI’s ingredients or products.
The strategic focus of NBI in recent years has been to address the emerging public health issues of diabetes, hypertension and obesity (particularly in children), by developing natural, plant-based substitutes for the sugar, salt and fat content in consumer goods. Natural alternatives are in high demand and an option that many Governments are backing with regulatory and financial support.
NBI is well placed to bridge the gap between the needs of the food manufacturing industry and the medical profession. As incomes rise in developing countries, consumers themselves are also demanding high quality food products that provide nutritional value and are safe to eat.
NBI has a distinctive capability, with its leading R&D and nutritional product development facilities, to provide ready-for-market products to health and natural/herbal medicine markets in Australia, Asia the Middle East, Latin America and Europe.
NBI has recently embarked on a major project in Brunei to propagate and utilise the medicinal plants found in the natural rainforests of the Borneo region.
The commercialisation of the research currently being undertaken in Brunei is anticipated to boost the position of NBI in the global herbal medicine market.